
CAS Name: 5-(2-Cyclohexen-1-yl)dihydro-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione
Additional Names: 5-allyl-5-(2-cyclohexen-1-yl)-2-thiobarbituric acid; 5-(2-cyclohexen-1-yl)-5-allyl-2-...
Literature References: Prepn: Volwiler, Tabern, US 2153730 (1939 to Abbott).
CAS Name: 10H-Phenothiazine-10-carboxylic acid 2-[2-(dimethylamino)ethoxy]ethyl ester
Additional Names: b-dimethylaminoethoxyethyl phenothiazine-10-carboxylate
Trademarks: Tussidin; Cotrane ...
Literature References: Prepn: von Seeman, US 2778824 (1957 to American Home Prod.).
CAS Name: 2,6-Divanillylidenecyclohexanone
Additional Names: 2,6-bis(4-hydroxy-3-methoxybenzylidene)cyclohexanone; divanillalcyclohexanone
Trademarks: Beveno (Fischer); Divanil; Divanon (obs...
Literature References: Prepn: Vorländer, Koch, Ber. 62, 534 (1929); Rumpel, AT 180258 (1954 to Chem-Pharm. Fabrik Waldheim).
CAS Name: 9-[3-[(1-Methylethyl)amino]propyl]-9H-fluorene-9-carboxamide
Additional Names: 9-carbamoyl-9-(3-isopropylaminopropyl)fluorene; 9-[3-(isopropylamino)propyl]-9-(aminocarboyl)fluorene; r...
Literature References: Prepn: W. B. Lacefield, R. L. Simon, US 4197313 and US 4452745 (1980, 1984 both to Lilly). Pharmacokinetics in animals: T. L. Lindstrom, G. W. Whitaker, Drug Metab. Dispos. 12, 683 (1984). Metabolism: eidem, ibid. 691. LC determn in biological fluids: K. Z. Farid et al., J. Chromatogr. 337, 329 (1985). Toxicological studies: G. E. Sandusky, Jr., D. B. Meyers, Fundam. Appl. Toxicol. 5, 175 (1985). Clinical evaluation in cardiac arrhythmias: P. F. Nestico et al., Am. J. Cardiol. 59, 1332 (1987); P. J. Podrid et al., ibid. 61, 764 (1988).
CAS Name: 1-Butoxy-3-phenoxy-2-propanolTrademarks: Valbil (Procter Gamble)
Percent Composition: C 69.61%, H 8.99%, O 21.40%
Literature References: Prepn: W. F. Minor et al., J. Am. Chem. Soc. 76, 2993 (1954). Prepn and use as choleretic: H. Hoffmann et al., DE 2120396; eidem, US 3839587 (1972, 1974 both to Klinge). Pharmacology: G. Hofrichter et al., Arzneim.-Forsch. 24, 111 (1974). Pharmacokinetics, metabolism: K. Rehm et al., ibid. 26, 813 (1976). Spasmolytic action: R. Eisenburger, ibid. 27, 1429 (1977). Clinical studies: C. Wolf et al., Muench. Med. Wochenschr. 118, 1285 (1976); W. E. Scholing, W. Weinert, ibid. 120, 143 (1978); U. Ritter, H. J. Kyrein, Arzneim.-Forsch. 33, 891 (1983).
CAS Name: 2-(4-Chlorophenyl)-4-thiazoleacetic acid
Additional Names: 2-(p-chlorophenyl)thiazol-4-ylacetic acid; acidum fenclozicumTrademarks: Myalex (ICI)
Percent Composition: C 52.08%, H 3....
Literature References: Prepn: W. Hepworth, G. J. Stacey, NL 6614130; eidem, US 3538107 (1967, 1970 both to ICI); Aries, FR 1561433 (1969), C.A. 72, 43654y (1970). Pharmacology: W. Hepworth et al., Nature 221, 582 (1969); Newbould, Br. J. Pharmacol. 35, 487 (1969). Metabolic studies: Foulkes, J. Pharmacol. Exp. Ther. 172, 115, 449 (1970). Clinical evaluation: Chalmers et al., Ann. Rheum. Dis. 28, 590, 595 (1969).
CAS Name: 2-[(2,6-Dichlorophenyl)methylene]-N-hydroxyhydrazinecarboximidamide
Additional Names: 1-[(2,6-dichlorobenzylidene)amino]-3-hydroxyguanidinePercent Composition: C 38.89%, H 3.26%, Cl 2...
Literature References: Prepn: W. J. Houlihan, R. E. Manning, DE 1902449; eidem, US 3591636 (1969, 1971 both to Sandoz). Pharmacological study: J. C. Doxey, A. S. Hersom, Br. J. Pharmacol. 70, 171 (1980).
CAS Name: a-Bicyclo[2.2.1]hept-5-en-2-yl-a-phenyl-1-piperidinepropanol
Additional Names: a-5-norbornen-2-yl-a-phenyl-1-piperidinepropanol; 3-piperidino-1-phenyl-1-bicycloheptenyl-1-propanol; 1-...
Literature References: Prepn: W. Klavehn, US 2789110 (1957 to Knoll). Toxicology study: C. Hanna, Toxicol. Appl. Pharmacol. 2, 379 (1960).
CAS Name: 1-Bromo-2-methylbutane
Additional Names: d-pri-act-amyl bromide; L-1-bromo-2-methylbutane
Percent Composition: C 39.76%, H 7.34%, Br 52.90%
Literature References: Prepn: W. Marckwald, Ber. 37, 1038 (1904); H. O. Jones, J. Chem. Soc. 87, 135 (1905); R. P. Frohardt et al., J. Am. Chem. Soc. 81, 5500 (1959).
CAS Name: a-Methyl-3-phenoxybenzeneacetic acid
Additional Names: (±)-m-phenoxyhydratropic acid; a-dl-2-(3-phenoxyphenyl)propionic acidPercent Composition: C 74.36%, H 5.82%, O 19.81%
Literature References: Prepn: W. S. Marshall, FR 2015728; eidem, US 3600437 (1970, 1971 both to Lilly). Pharmacology: Rubin et al., J. Pharm. Sci. 60, 1797 (1971); 61, 800 (1972); Herrmann, Proc. Soc. Exp. Biol. Med. 139, 548 (1972). Metabolism: Rubin et al., J. Pharmacol. Exp. Ther. 183, 449 (1972). Toxicology: J. L. Emmerson et al., Toxicol. Appl. Pharmacol. 25, 444 (1973). Comprehensive description: C. K. Ward, R. E. Schirmer, Anal. Profiles Drug Subs. 6, 161-182 (1977). Review: R. N. Brogden et al., Drugs 13, 241-265 (1977); R. Nickander et al., in Pharmacological and Biochemical Properties of Drug Substances vol. 1, M. E. Goldberg, Ed. (Am. Pharm. Assoc., Washington, DC, 1977) pp 183-213.
即日起可免费注册成为会员, 建立企业产品库, 免费上传产品目录, 企业介绍等. 让你的产品直接呈现给客户.
试运营阶段,所有广告业务5折优惠
